Our protocol describes a simplified method for the introduction of a covalent biotin modification to the proteins in the vicinity of a target protein in Paramecium (Figure 1A). These biotinylated proteins can then be further enriched using a streptavidin-pulldown and identified using mass spectrometry20. To demonstrate a practical use case of the method, we applied the protocol to the Nowa1 protein. This protein is essential for the genomic rearrangement process and has dynamic alterations in its localization12. In the early stages, it remains in the old somatic nucleus and fragments, but later it is located in the new developing nucleus. Notably, our previous attempts for a tag-mediated enrichment of the Nowa1 interacting proteins were unsuccessful (unpublished results). This was likely due to the complex repeats bearing similarity to the prion protein PrP27 that could cause self-aggregation under non-optimal conditions during the pulldown procedure21. We PCR amplified the Nowa1 coding region together with its upstream non-coding region containing the promoter. The product was then inserted in frame with a codon-optimized turboID encoding sequence (Figure 1B). To avoid transgene-induced silencing caused by the injection of circular DNA in Paramecium, the vector was linearized before injection. The linearized and purified DNA was then microinjected into the somatic nucleus (MAC) as described in this protocol. A dispersed droplet confined within the darker region of the somatic nucleus became visible in some of the successful injections (Figure 1C). The successful injection and the amplification of the DNA by the cells during cell division were then verified by PCR. As expected, 40-50% of the cells were positive for the injected DNA of the Nowa1 construct (expected product size 685 bp) (Figure 2). The next step was to verify the presence of the protein encoded by the injected DNA. Since the recipient vector contains the turboID sequence flanked by a triple HA tag, we used immunofluorescence staining to detect the tag. This allowed us to verify if the injected cells are expressing the fusion protein and if it was properly localized. We used late-stage cells that showed localization of the fusion protein in the two new developing nuclei, as previously observed for the wild-type Nowa1 protein12. The individual injected cell lines showed different levels of the fusion protein (Figure 3). A lower expression level can be beneficial for applications where reduced background is desirable, but in this case, we opted for maximal signal and proceeded with clone 2, which showed the highest expression. We then collected samples during different developmental stages to track the localization of the fusion protein. The protein was initially localized in the skeins formed from the old somatic nucleus and in the separated nuclear fragments during the early stages of autogamy. Upon the appearance of the nuclear anlagen, the fusion protein transitioned towards these new developing nuclei (Figure 4). To foster the biotinylation of the proximal proteome at the different stages, we supplemented the culture with 500 μM biotin for 2 h before harvesting the cells for IF. We visualized the biotin-labeled proteins via an IF staining using a fluorescently tagged streptavidin. The observed signal corresponded to the localization of the HA-tagged fusion protein. Importantly, it was possible to obtain biotinylation localization that is specific for the different nuclear developmental stages, as even a short incubation with biotin is sufficient for achieving significant biotinylation (Figure 4). Additionally, without the addition of supplemental biotin, only negligible biotinylation was detectable in the injected cells. In wild-type cells, the addition of supplemental biotin caused no detectable biotinylation (Figure 5A). Notably, the biotin was not merely accumulating in the developing nucleus, as even in denaturing conditions, it remains attached to the proteins. (Figure 5B). Using streptavidin-coated magnetic beads, it was possible to selectively enrich the biotinylated proteins (Figure 6). The enriched proteins can be identified using mass spectrometry. In these subsequent protein identification experiments, the non-supplemented culture, as well as cells expressing a non-fused turboID protein, can be used as background control groups.

Figure 1: Overview of the procedure for proximity biotinylation in P. tetraurelia. (A) Generalized outline of the protocol. (B) Cloning principle for the plug-and-play turboID recipient vector and the resulting construct for the Nowa1 fusion protein. The 3'UTR region used in this plasmid is derived from CenH3a. (C) Visible diffuse droplet contained within the darker area corresponding to the somatic nucleus (MAC) upon a successful injection of DNA. Please click here to view a larger version of this figure.

Figure 2: PCR test for successful injection. Agarose gel analysis of PCR reaction for a product with a forward primer specific for the upstream region encoding for ampicillin resistance (amp start) and a reverse primer complementary to Nowa1. The arrowhead shows the expected product size. Please click here to view a larger version of this figure.

Figure 3: Immunofluorescence staining to validate the correct localization of the turboID fusion protein. Immunofluorescence staining using rabbit-anti-HA primary antibody (1:100) and goat-anti-rabbit Alexa Fluor 568 conjugated secondary antibody (1:1000) of monoclonal Paramecium lines with a positive PCR signal for the DNA encoding a Nowa1-HA-turboID fusion protein. Scale 20 μm. Please click here to view a larger version of this figure.

Figure 4: Nowa1-specific biotinylation at different developmental stages. Immunofluorescence staining of the monoclonal line 2 at progressing stages during the formation of the new somatic nucleus. The culture medium was supplemented with 500 μM biotin for optimal turboID activity. HA-tag was detected as in Figure 3, and biotin was detected using Streptavidin-FITC (1:200). Scale 20 μm. Please click here to view a larger version of this figure.

Figure 5: Efficient proximity labeling by turboID requires supplemental biotin in the culture. (A) Immunofluorescence staining of wt and injected cells in the late developmental stage showing the expression of Nowa1-HA-turboID and the observed biotinylation with 500 μM supplemental biotin. HA-tag and biotin were detected as in Figure 4. Scale 20 μm. (B) Western blot analysis for biotin using HRP-streptavidin of wt cells cultured with 500 μM biotin and turboID injected cells with and without biotin. Please click here to view a larger version of this figure.

Figure 6: Enrichment of biotinylated proteins with streptavidin magnetic beads. Western blot analysis for biotin of samples from a pulldown experiment using streptavidin-coated magnetic beads. The samples are: Nowa1-HA-turboID cell lysate (input), the unbound fraction (flowthrough), the wash steps (wash 1-6), and the proteins bound to the beads (output). Please click here to view a larger version of this figure.